Standard BioTools Shares Fall After Downgrade From KeyBanc

MT Newswires Live02-28

Standard BioTools' (LAB) shares were down about 9% in recent Thursday trading after KeyBanc downgraded the company's stock to sector weight from overweight.

The downgrade followed the company's "disappointing" full year 2025 guidance, Keybanc said in an earnings recap Wednesday.

The firm said Standard BioTools' 2025 revenue outlook of $165 million to $175 million fell short of the $186.9 million consensus estimate and KeyBanc's $185 million projection.

"The company attributed its guidance to the proposed White House [National Institutes of Health] spending cut that may drive cautious spending for its academic customers," KeyBanc said.

Trading volume stood at more than 3.6 million shares against a daily average of roughly 1.7 million.

Price: 1.07, Change: -0.11, Percent Change: -8.97

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2514339900?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-28 02:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514339900","market":"nz","top_or_hot":-1,"title":"Standard BioTools Shares Fall After Downgrade From KeyBanc","media":"MT Newswires Live","content":"<html><body><p> Standard BioTools' (LAB) shares were down about 9% in recent Thursday trading after KeyBanc downgraded the company's stock to sector weight from overweight.</p><p>The downgrade followed the company's \"disappointing\" full year 2025 guidance, Keybanc said in an earnings recap Wednesday.</p><p>The firm said Standard BioTools' 2025 revenue outlook of $165 million to $175 million fell short of the $186.9 million consensus estimate and KeyBanc's $185 million projection.</p><p>\"The company attributed its guidance to the proposed White House [National Institutes of Health] spending cut that may drive cautious spending for its academic customers,\" KeyBanc said.</p><p>Trading volume stood at more than 3.6 million shares against a daily average of roughly 1.7 million.</p><p>Price: 1.07, Change: -0.11, Percent Change: -8.97</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Standard BioTools Shares Fall After Downgrade From KeyBanc</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStandard BioTools Shares Fall After Downgrade From KeyBanc\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-28 02:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Standard BioTools' (LAB) shares were down about 9% in recent Thursday trading after KeyBanc downgraded the company's stock to sector weight from overweight.</p><p>The downgrade followed the company's \"disappointing\" full year 2025 guidance, Keybanc said in an earnings recap Wednesday.</p><p>The firm said Standard BioTools' 2025 revenue outlook of $165 million to $175 million fell short of the $186.9 million consensus estimate and KeyBanc's $185 million projection.</p><p>\"The company attributed its guidance to the proposed White House [National Institutes of Health] spending cut that may drive cautious spending for its academic customers,\" KeyBanc said.</p><p>Trading volume stood at more than 3.6 million shares against a daily average of roughly 1.7 million.</p><p>Price: 1.07, Change: -0.11, Percent Change: -8.97</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LAB","symbol_name":"Standard BioTools Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2514339900","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514339900","pubTimestamp":1740682739,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Standard BioTools'  shares were down about 9% in recent Thursday trading after KeyBanc downgraded the company's stock to sector weight from overweight.The downgrade followed the company's \"disappointing\" full year 2025 guidance, Keybanc said in an earnings recap Wednesday.The firm said Standard BioTools' 2025 revenue outlook of $165 million to $175 million fell short of the $186.9 million consensus estimate and KeyBanc's $185 million projection.\"The company attributed its guidance to the proposed White House [National Institutes of Health] spending cut that may drive cautious spending for its academic customers,\" KeyBanc said.Trading volume stood at more than 3.6 million shares against a daily average of roughly 1.7 million.Price: 1.07, Change: -0.11, Percent Change: -8.97","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"LAB":"Standard BioTools Inc.","SMP":"Standard Motor Products Inc"},"translate_title":"KeyBanc降级后Standard BioTools股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LAB":0.9,"SMP":1},"content_text":"Standard BioTools' (LAB) shares were down about 9% in recent Thursday trading after KeyBanc downgraded the company's stock to sector weight from overweight.The downgrade followed the company's \"disappointing\" full year 2025 guidance, Keybanc said in an earnings recap Wednesday.The firm said Standard BioTools' 2025 revenue outlook of $165 million to $175 million fell short of the $186.9 million consensus estimate and KeyBanc's $185 million projection.\"The company attributed its guidance to the proposed White House [National Institutes of Health] spending cut that may drive cautious spending for its academic customers,\" KeyBanc said.Trading volume stood at more than 3.6 million shares against a daily average of roughly 1.7 million.Price: 1.07, Change: -0.11, Percent Change: -8.97","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514339900","isCrawlerRequest":true}